West Pharmaceutical Services, Inc. (WST)

WST Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,500	23,723	26,053	17,424	34,744	20,944
Market Cap Growth	-6.14%	-8.95%	49.53%	-49.85%	65.89%	88.30%
Enterprise Value	19,174	23,540	25,461	16,995	34,372	20,754
Last Close Price	271.04	326.76	350.42	233.67	464.54	280.05
PE Ratio	40.15	48.15	43.91	29.74	52.50	60.50
Forward PE	36.23	45.90	42.23	34.84	53.55	58.12
PS Ratio	6.50	8.20	8.83	6.04	12.27	9.76
PB Ratio	6.39	8.84	9.04	6.49	14.88	11.29
P/TBV Ratio	6.65	9.25	9.45	6.81	15.78	12.23
P/FCF Ratio	51.44	85.83	62.86	39.65	105.09	70.26
P/OCF Ratio	28.11	36.31	33.55	24.07	59.49	44.33
PEG Ratio	2.98	5.25	5.39	2.31	2.37	3.06
EV/Sales Ratio	6.35	8.14	8.63	5.89	12.14	9.67
EV/EBITDA Ratio	23.93	31.43	30.19	19.22	38.58	39.03
EV/EBIT Ratio	30.13	39.66	36.05	22.25	44.72	49.11
EV/FCF Ratio	50.58	85.17	61.43	38.68	103.97	69.62
Debt / Equity Ratio	0.10	0.11	0.11	0.12	0.14	0.18
Debt / EBITDA Ratio	0.36	0.39	0.35	0.35	0.36	0.60
Debt / FCF Ratio	0.80	1.11	0.75	0.72	0.98	1.11
Asset Turnover	0.78	0.77	0.79	0.83	0.93	0.84
Inventory Turnover	4.63	4.67	4.28	4.41	4.73	4.95
Quick Ratio	2.02	1.93	2.07	2.73	2.13	1.99
Current Ratio	2.87	2.80	2.88	3.70	2.93	2.73
Return on Equity (ROE)	16.95%	17.71%	21.32%	23.34%	31.59%	20.20%
Return on Assets (ROA)	10.22%	9.93%	11.86%	13.78%	15.73%	10.29%
Return on Capital (ROIC)	12.40%	12.01%	14.25%	16.86%	19.82%	12.92%
Return on Capital Employed (ROCE)	18.30%	19.20%	22.40%	24.70%	28.30%	18.50%
Earnings Yield	2.52%	2.08%	2.28%	3.36%	1.91%	1.65%
FCF Yield	1.94%	1.17%	1.59%	2.52%	0.95%	1.42%
Dividend Yield	0.32%	0.25%	0.22%	0.31%	0.15%	0.23%
Payout Ratio	12.59%	12.00%	9.61%	9.23%	7.72%	13.89%
Buyback Yield / Dilution	1.55%	2.13%	0.66%	0.66%	-0.66%	-0.53%
Total Shareholder Return	1.88%	2.37%	0.88%	0.97%	-0.51%	-0.30%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q